secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-02-06T23:59:59+00:00
Accession:  0001493152-26-005640
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma files Series A Convertible Preferred Stock with 80% discount conversion and price protection
--------------------------------------------------------------------------------

- Filed Certificate of Designation for 25,000 shares of Series A Convertible Preferred Stock on Feb 2, 2026.
- Conversion price at 80% of lowest closing price in 5 prior trading days; floor price at 20% of Nasdaq minimum price.
- Beneficial ownership conversion cap at 4.99% (can increase to 9.99% with 61-day notice).
- Holders get participation rights in 30% of future financings for 6 months; no voting rights.
- Shares rank senior to common; price protection adjusts conversion price on lower-priced issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226005640/0001493152-26-005640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226005640/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer